Elizabeth Warren

So for years, lobbyists and antitax extremists have worked to gut the IRS, to prevent it from chasing down wealthy tax cheats.

Wow. Well, you know, we must ensure that drug companies do not rely on tricks in order to avoid competition.

So last year, Congress passed the Inflation Reduction Act, which finally gives HHS the authority to negotiate drug prices for a select number of high-priced brand-name drugs.

Despite these wins, there is more that we need to do to reduce exorbitant drug prices for all Americans.

The name of the game is volume.

Wow. Well, you know, we must ensure that drug companies do not rely on tricks in order to avoid competition.

Okay. So drug companies use these tricks, and a lot of others, to keep their monopolies and keep pushing prices higher and higher and higher.

So, think about that. More than three out of four new patent applications for pharmaceuticals are for existing drugs.

But we also cannot lose sight of the ways that drug companies continue to abuse our intellectual property laws to drive out competition, to jack up prices, and to protect their profits.

Despite these wins, there is more that we need to do to reduce exorbitant drug prices for all Americans.

So last year, Congress passed the Inflation Reduction Act, which finally gives HHS the authority to negotiate drug prices for a select number of high-priced brand-name drugs.

It seems to me the solution is clear. It is time to expand Medicare to cover dental care, something I have long supported.

Since Medicare was established in 1965, it has not covered routine dental benefits.

Or we can spend nearly a trillion dollars in overpayments to insurance companies for crummy coverage that beneficiaries do not use.

It seems to me the solution is clear. It is time to expand Medicare to cover dental care, something I have long supported.

CMS should absolutely finalize this rule. But I want to argue here that CMS needs to go further and end these insurance industry scams.

Since Medicare was established in 1965, it has not covered routine dental benefits.

The name of the game is volume. The more volume a drug company has with a particular PBM, and the greater the drug company's market share, the better the potential deal that the drug company can offer as an inducement to disfavor rival…

Wow. Well, you know, we must ensure that drug companies do not rely on tricks in order to avoid competition.

So drug companies use these tricks, and a lot of others, to keep their monopolies and keep pushing prices higher and higher and higher.

So last year, Congress passed the Inflation Reduction Act, which finally gives HHS the authority to negotiate drug prices for a select number of high-priced brand-name drugs.

Despite these wins, there is more that we need to do to reduce exorbitant drug prices for all Americans.

More than three out of four new patent applications for pharmaceuticals are for existing drugs.

But we also cannot lose sight of the ways that drug companies continue to abuse our intellectual property laws to drive out competition.

I urge you to use that authority and I urge my colleagues here in Congress to do our part to protect American families and small businesses from yet another banking crisis.